MGP.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 liep. 2023 @ 18:29):

Stats
Šios dienos apimtis	719 903
Vidutinė apimtis	1.99M
Rinkos kapitalizacija	268.14M
EPS	£0 ( 2023-09-25 )
Last Dividend	£1.880 ( 2023-06-22 )
Next Dividend	£0 ( N/A )
P/E	35.33
ATR14	£7.10 (3.37%)

Tūris Koreliacija

Ilgas: 0.28 (neutral)

Trumpas: 0.00 (neutral)

Signal:(61.419) Neutral

Medica Group PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Medica Group PLC Koreliacija - Valiuta/Žaliavos

-0.25
( neutral )

0.45
( neutral )

0.57
( weak )

-0.10
( neutral )

-0.06
( neutral )

0.25
( neutral )

Medica Group PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£76.98M
Bruto pelnas:	£37.18M (48.30 %)
EPS:	£0.0588

FY	2022
Pajamos:	£76.98M
Bruto pelnas:	£37.18M (48.30 %)
EPS:	£0.0588

FY	2021
Pajamos:	£61.91M
Bruto pelnas:	£31.39M (50.71 %)
EPS:	£0.0521

FY	2020
Pajamos:	£36.81M
Bruto pelnas:	£17.45M (47.41 %)
EPS:	£0.0121

Financial Reports:

No articles found.

Medica Group PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0.930 (N/A)	£0 (N/A)	£1.880 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Medica Group PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.92 - Stable (18.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.550	2017-09-28
Last Dividend	£1.880	2023-06-22
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	£12.79	--
Avg. Dividend % Per Year	1.00%	--
Score	3.72	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.92
Div. Directional Score	9.03	--

Next Divdend (Est)
(2024-06-03)

£2.12 Estimate 3.50 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.72

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2017	£0	0.00%
2018	£1.850	1.53%
2019	£2.35	1.88%
2020	£0.850	0.55%
2021	£2.59	2.15%
2022	£2.72	1.58%
2023	£1.880	1.35%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SCF.L	Dividend Knight	2023-07-06	Quarterly	30	2.18%
HUR.L	Dividend King	2023-06-08	Insufficient data to determine frequency	2	21.63%
BERI.L	Dividend Knight	2023-09-28	Quarterly	19	2.36%
WINK.L	Dividend King	2023-07-20	Quarterly	15	3.81%
NAIT.L	Dividend Knight	2023-07-20	Quarterly	53	2.33%
EDIN.L	Dividend King	2023-06-08	Quarterly	53	2.46%
SNWS.L	Dividend Knight	2023-06-08	Annually	32	4.00%
ITRK.L	Dividend Knight	2023-09-14	Semi-Annually	22	1.44%
BRSC.L	Dividend Knight	2023-05-18	Semi-Annually	47	1.21%
PFD.L	Dividend Knight	2023-06-29	Sporadic	20	0.70%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0935	1.500	8.13	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0835	1.200	7.22	8.66	[0 - 0.3]
returnOnEquityTTM	0.124	1.500	9.73	10.00	[0.1 - 1]
payoutRatioTTM	0.462	-1.000	5.38	-5.38	[0 - 1]
currentRatioTTM	1.672	0.800	6.64	5.31	[1 - 3]
quickRatioTTM	0.639	0.800	-0.948	-0.758	[0.8 - 2.5]
cashRatioTTM	0.639	1.500	7.56	10.00	[0.2 - 2]
debtRatioTTM	0.130	-1.500	7.84	-10.00	[0 - 0.6]
interestCoverageTTM	13.48	1.000	6.12	6.12	[3 - 30]
operatingCashFlowPerShareTTM	0.0707	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0472	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.183	-1.500	9.27	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.483	1.000	5.28	5.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.783	1.000	6.76	6.76	[0.2 - 2]
assetTurnoverTTM	0.893	0.800	7.38	5.91	[0.5 - 2]
Total Score				12.15

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.39	1.000	6.42	0	[1 - 100]
returnOnEquityTTM	0.124	2.50	9.83	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0472	2.00	9.98	10.00	[0 - 30]
dividendYielPercentageTTM	0.887	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0707	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.462	1.500	5.38	-5.38	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.114	1.000	9.66	0	[0.1 - 0.5]
Total Score				5.92

Medica Group PLC

Medica Group Plc, together with its subsidiaries, provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom, Ireland, and the United States. It offers NightHawk, an out-of-hours service, which provides emergency reporting services through radiologists for stroke and major trauma; cardiac, computerized tomography (CT) colonography, PET CT and nuclear medicine, CT Cone Beam, DEXA, audit, and MR prostate services; AI powered CT Brain solution for detection of intracranial haemorrhage to acute teleradiology reporting workflow; and elective scanning services. The company also provides routine plain film and radiographer plain film services, and managed services, as well as ophthalmology services and various imaging lab services. Medica Group Plc was founded in 2004 and is headquartered in Hastings, the United Kingdom.